Endocrinology, Vol 134, 2404-2409, Copyright © 1994 by Endocrine Society

ARTICLES

Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats

MS Lewitt, H Saunders, JL Phuyal and RC Baxter
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Insulin-like growth factor-binding protein-3 (IGFBP-3), after first associating with IGF-I or IGF-II, is able to associate with the acid- labile subunit (ALS) and form a 140-kDa complex. To investigate the factors regulating ternary complex formation in vivo, human (h) IGFBP- 3, hIGF-I, and hALS were administered in various combinations to GH- deficient (dw/dw) rats. hIGFBP-3 had a complex pattern of disappearance from the rat circulation, with an initial phase lasting minutes and a prolonged phase(s) lasting hours. If coinjected with hIGF-I, significantly more hIGFBP-3 was retained over 2 h. The molecular distribution of hIGFBP-3 was determined after size-separation chromatography. After an iv bolus of hIGFBP-3, 36.1 +/- 5.0% was in the 140-kilodalton complex at 5 min; this increased to 55.1 +/- 7.1% if hIGF-I was coinjected (P < 0.05). The 140-kDa complex disappeared slowly over hours, whereas 50- and 30-kDa forms of hIGFBP-3 cleared rapidly, with half-lives of minutes. To determine the importance of ALS in regulating the molecular distribution of hIGFBP-3, hALS was coinjected. Immunoreactive hALS disappeared slowly from the circulation and was shown to retain functional activity after 2 h in vivo. Coadministration of hALS did not influence the pattern of ternary complex formation, consistent with the presence of excess endogenous rat ALS. We conclude that ALS circulates in excess even in GH deficiency, is retained in the circulation for hours, and determines the stability of the 140-kDa complex, whereas IGF-I is a limiting factor in ternary complex formation by hIGFBP-3.

This article has been cited by other articles:

				R. P. Rhoads, J. W. Kim, B. J. Leury, L. H. Baumgard, N. Segoale, S. J. Frank, D. E. Bauman, and Y. R. Boisclair Insulin Increases the Abundance of the Growth Hormone Receptor in Liver and Adipose Tissue of Periparturient Dairy Cows J. Nutr., May 1, 2004; 134(5): 1020 - 1027. [Abstract] [Full Text] [PDF]

				D. A. M. Salih, G. Tripathi, C. Holding, T. A. M. Szestak, M. I. Gonzalez, E. J. Carter, L. J. Cobb, J. E. Eisemann, and J. M. Pell Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice PNAS, March 23, 2004; 101(12): 4314 - 4319. [Abstract] [Full Text] [PDF]

				S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF]

				S.-E. Kong, S. M. Firth, R. C. Baxter, and P. J. D. Delhanty Regulation of the acid-labile subunit in sustained endotoxemia Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E692 - E701. [Abstract] [Full Text] [PDF]

				S. M. Firth, F. MCDougall, A. J. MCLachlan, and R. C. Baxter Impaired Blockade of Insulin-Like Growth Factor I (IGF-I)-Induced Hypoglycemia by IGF Binding Protein-3 Analog with Reduced Ternary Complex-Forming Ability Endocrinology, May 1, 2002; 143(5): 1669 - 1676. [Abstract] [Full Text] [PDF]

				T. Laursen, A. Flyvbjerg, J. O. L. Jørgensen, R. C. Baxter, and J. S. Christiansen Stimulation of the 150-Kilodalton Insulin-Like Growth Factor-Binding Protein-3 Ternary Complex by Continuous and Pulsatile Patterns of Growth Hormone (GH) Administration in GH-Deficient Patients J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4310 - 4314. [Abstract] [Full Text]

				E. Svanberg, R. A. Frost, C. H. Lang, J. Isgaard, L. S. Jefferson, S. R. Kimball, and T. C. Vary IGF-I/IGFBP-3 binary complex modulates sepsis-induced inhibition of protein synthesis in skeletal muscle Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1145 - E1158. [Abstract] [Full Text] [PDF]

				S.-A. Wandji, J. E. Gadsby, F. A. Simmen, J. A. Barber, and J. M. Hammond Porcine Ovarian Cells Express Messenger Ribonucleic Acids for the Acid-Labile Subunit and Insulin-Like Growth Factor Binding Protein-3 during Follicular and Luteal Phases of the Estrous Cycle Endocrinology, July 1, 2000; 141(7): 2638 - 2647. [Abstract] [Full Text] [PDF]

				A. Suwanichkul, Y. R. Boisclair, R. C. Olney, S. K. Durham, and D. R. Powell Conservation of a Growth Hormone-Responsive Promoter Element in the Human and Mouse Acid-Labile Subunit Genes Endocrinology, February 1, 2000; 141(2): 833 - 838. [Abstract] [Full Text] [PDF]

				K. R. Kritsch, D. J. Huss, and D. M. Ney Greater potency of IGF-I than IGF-I/BP-3 complex in catabolic parenterally fed rats Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E252 - E262. [Abstract] [Full Text] [PDF]

				H. Olivecrona, A. Hilding, C. Ekström, H. Barle, B. Nyberg, C. Möller, P. J. Delhanty, R. C. Baxter, B. Angelin, T. J. Ekström, et al. Acute and Short-Term Effects of Growth Hormone on Insulin-Like Growth Factors and Their Binding Proteins: Serum Levels and Hepatic Messenger Ribonucleic Acid Responses in Humans J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 553 - 560. [Abstract] [Full Text]

				S. M. Twigg, M. C. Kiefer, J. Zapf, and R. C. Baxter Insulin-like Growth Factor-binding Protein 5 Complexes with the Acid-labile Subunit. ROLE OF THE CARBOXYL-TERMINAL DOMAIN J. Biol. Chem., October 30, 1998; 273(44): 28791 - 28798. [Abstract] [Full Text] [PDF]

				S. M. Twigg and R. C. Baxter Insulin-like Growth Factor (IGF)-binding Protein 5 Forms an Alternative Ternary Complex with IGFs and the Acid-labile Subunit J. Biol. Chem., March 13, 1998; 273(11): 6074 - 6079. [Abstract] [Full Text] [PDF]

				R. A. Hill and J. M. Pell Regulation of Insulin-Like Growth Factor I (IGF-I) Bioactivity in Vivo: Further Characterization of an IGF-I-Enhancing Antibody Endocrinology, March 1, 1998; 139(3): 1278 - 1287. [Abstract] [Full Text] [PDF]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				A. G. Johansson, E. F. Eriksen, E. Lindh, B. Langdahl, W. F. Blum, A. Lindahl, O. Ljunggren, and S. Ljunghall Reduced Serum Levels of the Growth Hormone-Dependent Insulin-Like Growth Factor Binding Protein and a Negative Bone Balance at the Level of Individual Remodeling Units in Idiopathic Osteoporosis in Men J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2795 - 2798. [Abstract] [Full Text] [PDF]